139 related articles for article (PubMed ID: 37003305)
1. Evaluation of a panel of therapeutic antibody clinical candidates for efficacy against SARS-CoV-2 in Syrian hamsters.
Cong Y; Mucker EM; Perry DL; Dixit S; Kollins E; Byrum R; Huzella L; Kim R; Josleyn M; Kwilas S; Stefan C; Shoemaker CJ; Koehler J; Coyne S; Delp K; Liang J; Drawbaugh D; Hischak A; Hart R; Postnikova E; Vaughan N; Asher J; St Claire M; Hanson J; Schmaljohn C; Eakin AE; Hooper JW; Holbrook MR
Antiviral Res; 2023 May; 213():105589. PubMed ID: 37003305
[TBL] [Abstract][Full Text] [Related]
2. Neutralizing Monoclonal Antibodies That Target the Spike Receptor Binding Domain Confer Fc Receptor-Independent Protection against SARS-CoV-2 Infection in Syrian Hamsters.
Su W; Sia SF; Schmitz AJ; Bricker TL; Starr TN; Greaney AJ; Turner JS; Mohammed BM; Liu Z; Choy KT; Darling TL; Joshi A; Cheng KM; Wong AYL; Harastani HH; Nicholls JM; Whelan SPJ; Bloom JD; Yen HL; Ellebedy AH; Boon ACM
mBio; 2021 Oct; 12(5):e0239521. PubMed ID: 34517754
[TBL] [Abstract][Full Text] [Related]
3. Disruption of Adaptive Immunity Enhances Disease in SARS-CoV-2-Infected Syrian Hamsters.
Brocato RL; Principe LM; Kim RK; Zeng X; Williams JA; Liu Y; Li R; Smith JM; Golden JW; Gangemi D; Youssef S; Wang Z; Glanville J; Hooper JW
J Virol; 2020 Oct; 94(22):. PubMed ID: 32900822
[TBL] [Abstract][Full Text] [Related]
4. Highly Neutralizing COVID-19 Convalescent Plasmas Potently Block SARS-CoV-2 Replication and Pneumonia in Syrian Hamsters.
Takamatsu Y; Imai M; Maeda K; Nakajima N; Higashi-Kuwata N; Iwatsuki-Horimoto K; Ito M; Kiso M; Maemura T; Takeda Y; Omata K; Suzuki T; Kawaoka Y; Mitsuya H
J Virol; 2022 Feb; 96(4):e0155121. PubMed ID: 34818068
[TBL] [Abstract][Full Text] [Related]
5. Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development.
Imai M; Iwatsuki-Horimoto K; Hatta M; Loeber S; Halfmann PJ; Nakajima N; Watanabe T; Ujie M; Takahashi K; Ito M; Yamada S; Fan S; Chiba S; Kuroda M; Guan L; Takada K; Armbrust T; Balogh A; Furusawa Y; Okuda M; Ueki H; Yasuhara A; Sakai-Tagawa Y; Lopes TJS; Kiso M; Yamayoshi S; Kinoshita N; Ohmagari N; Hattori SI; Takeda M; Mitsuya H; Krammer F; Suzuki T; Kawaoka Y
Proc Natl Acad Sci U S A; 2020 Jul; 117(28):16587-16595. PubMed ID: 32571934
[TBL] [Abstract][Full Text] [Related]
6. Coinfection by Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza A(H1N1)pdm09 Virus Enhances the Severity of Pneumonia in Golden Syrian Hamsters.
Zhang AJ; Lee AC; Chan JF; Liu F; Li C; Chen Y; Chu H; Lau SY; Wang P; Chan CC; Poon VK; Yuan S; To KK; Chen H; Yuen KY
Clin Infect Dis; 2021 Jun; 72(12):e978-e992. PubMed ID: 33216851
[TBL] [Abstract][Full Text] [Related]
7. Absence of Vaccine-enhanced Disease With Unexpected Positive Protection Against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by Inactivated Vaccine Given Within 3 Days of Virus Challenge in Syrian Hamster Model.
Li C; Chen YX; Liu FF; Lee AC; Zhao Y; Ye ZH; Cai JP; Chu H; Zhang RQ; Chan KH; Chiu KH; Lung DC; Sridhar S; Hung IF; To KK; Zhang AJ; Chan JF; Yuen KY
Clin Infect Dis; 2021 Aug; 73(3):e719-e734. PubMed ID: 33515458
[TBL] [Abstract][Full Text] [Related]
8. Hamsters as a Model of Severe Acute Respiratory Syndrome Coronavirus-2.
Braxton AM; Creisher PS; Ruiz-Bedoya CA; Mulka KR; Dhakal S; Ordonez AA; Beck SE; Jain SK; Villano JS
Comp Med; 2021 Oct; 71(5):398-410. PubMed ID: 34588095
[TBL] [Abstract][Full Text] [Related]
9. [Clinical symptoms and signs in hamsters during experimental infection with the SARS-CoV-2 virus (Coronaviridae:
Tuyskanova MS; Zhugunissov KD; Ozaslan M; Myrzakhmetova BS; Kutumbetov LB
Vopr Virusol; 2023 Dec; 68(6):513-525. PubMed ID: 38156567
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 Kappa Variant Shows Pathogenicity in a Syrian Hamster Model.
Yadav PD; Mohandas S; Shete AM; Nyayanit DA; Gupta N; Patil DY; Sapkal GN; Potdar V; Kadam M; Kumar A; Kumar S; Suryavanshi D; Mote CS; Abraham P; Panda S; Bhargava B
Vector Borne Zoonotic Dis; 2022 May; 22(5):289-296. PubMed ID: 35580212
[No Abstract] [Full Text] [Related]
11. Age-Dependent Progression of SARS-CoV-2 Infection in Syrian Hamsters.
Osterrieder N; Bertzbach LD; Dietert K; Abdelgawad A; Vladimirova D; Kunec D; Hoffmann D; Beer M; Gruber AD; Trimpert J
Viruses; 2020 Jul; 12(7):. PubMed ID: 32698441
[TBL] [Abstract][Full Text] [Related]
12. Convalescent human IgG, but not IgM, from COVID-19 survivors confers dose-dependent protection against SARS-CoV-2 replication and disease in hamsters.
King HAD; Dussupt V; Mendez-Rivera L; Slike BM; Tran U; Jackson ND; Barkei E; Zemil M; Tourtellott-Fogt E; Kuklis CH; Soman S; Ahmed A; Porto M; Kitajewski C; Spence B; Benetiene D; Wieczorek L; Kar S; Gromowski G; Polonis VR; Krebs SJ; Modjarrad K; Bolton DL
Front Immunol; 2023; 14():1138629. PubMed ID: 37026013
[TBL] [Abstract][Full Text] [Related]
13. ZRC3308 Monoclonal Antibody Cocktail Shows Protective Efficacy in Syrian Hamsters against SARS-CoV-2 Infection.
Yadav PD; Mendiratta SK; Mohandas S; Singh AK; Abraham P; Shete A; Bandyopadhyay S; Kumar S; Parikh A; Kalita P; Sharma V; Pandya H; Patel CG; Patel M; Soni S; Giri S; Jain M
Viruses; 2021 Dec; 13(12):. PubMed ID: 34960695
[TBL] [Abstract][Full Text] [Related]
14. Co-administration of Favipiravir and the Remdesivir Metabolite GS-441524 Effectively Reduces SARS-CoV-2 Replication in the Lungs of the Syrian Hamster Model.
Chiba S; Kiso M; Nakajima N; Iida S; Maemura T; Kuroda M; Sato Y; Ito M; Okuda M; Yamada S; Iwatsuki-Horimoto K; Watanabe T; Imai M; Armbrust T; Baric RS; Halfmann PJ; Suzuki T; Kawaoka Y
mBio; 2021 Feb; 13(1):e0304421. PubMed ID: 35100870
[TBL] [Abstract][Full Text] [Related]
15. Establishment of multicenter COVID-19 therapeutics preclinical test system in Republic of Korea.
Noh H; Yoon S; Kim SH; Kim J; Seo JS; Kim JJ; Park IH; Oh J; Bae JY; Lee GE; Woo SJ; Seo SM; Kim NW; Lee YW; Jang HJ; Hong SM; An SH; Lyoo KS; Yeom M; Lee H; Jung B; Yoon SW; Kang JA; Seok SH; Lee YJ; Kim SY; Kim YB; Hwang JY; On D; Lim SY; Kim SP; Jang JY; Lee H; Kim K; Lee HJ; Kim HB; Kim SB; Park JW; Jeong DG; Song D; Choi KS; Lee HY; Choi YK; Choi JA; Song M; Park MS; Seo JY; Shin JS; Yun JW; Nam KT; Seong JK
Pulm Pharmacol Ther; 2023 Jun; 80():102189. PubMed ID: 36634813
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic Administration of the Monoclonal Antibody Adintrevimab Protects against SARS-CoV-2 in Hamster and Non-Human Primate Models of COVID-19.
Zumbrun EE; Kaku CI; Dillinger L; Zak SE; Kuehne AI; Bakken RR; Koehler JW; Delp KL; Stefan CP; Kumar R; Kugelman JR; Moreau AM; Zeng X; Dye JM; Herbert AS; Narayan K; Walker LM
Antimicrob Agents Chemother; 2023 Jan; 67(1):e0135322. PubMed ID: 36519929
[TBL] [Abstract][Full Text] [Related]
17. Dynamic Changes of the Blood Chemistry in Syrian Hamsters Post-Acute COVID-19.
Hsu CJ; Lin WC; Chou YC; Yang CM; Wu HL; Cheng YH; Liu PC; Chang JY; Chen HY; Sun JR
Microbiol Spectr; 2022 Feb; 10(1):e0236221. PubMed ID: 35196799
[TBL] [Abstract][Full Text] [Related]
18. Simulation of the Clinical and Pathological Manifestations of Coronavirus Disease 2019 (COVID-19) in a Golden Syrian Hamster Model: Implications for Disease Pathogenesis and Transmissibility.
Chan JF; Zhang AJ; Yuan S; Poon VK; Chan CC; Lee AC; Chan WM; Fan Z; Tsoi HW; Wen L; Liang R; Cao J; Chen Y; Tang K; Luo C; Cai JP; Kok KH; Chu H; Chan KH; Sridhar S; Chen Z; Chen H; To KK; Yuen KY
Clin Infect Dis; 2020 Dec; 71(9):2428-2446. PubMed ID: 32215622
[TBL] [Abstract][Full Text] [Related]
19. Pathogenicity of SARS-CoV-2 Omicron (R346K) variant in Syrian hamsters and its cross-neutralization with different variants of concern.
Mohandas S; Yadav PD; Sapkal G; Shete AM; Deshpande G; Nyayanit DA; Patil D; Kadam M; Kumar A; Mote C; Jain R
EBioMedicine; 2022 May; 79():103997. PubMed ID: 35405385
[TBL] [Abstract][Full Text] [Related]
20. Therapy with a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody reduces disease severity and viral burden in golden Syrian hamsters.
Roberts A; Thomas WD; Guarner J; Lamirande EW; Babcock GJ; Greenough TC; Vogel L; Hayes N; Sullivan JL; Zaki S; Subbarao K; Ambrosino DM
J Infect Dis; 2006 Mar; 193(5):685-92. PubMed ID: 16453264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
